Thia Jim
FDA investigator
Appears on 1 document from 2018, mostly at sites in North Carolina. Most often cites design and construction features (21 CFR 211.42).
- 1
- Documents on file
- 7.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 7 observations- 21 CFR 211.42Design and construction features2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.25Personnel qualifications1
Activity by year
2018: 1
Where
North Carolina 1
Often inspects with
Is Thia Jim coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-12-13 | 483 Grifols Therapeutics LLCDec 13, 2018 · Clayton, North Carolina | Clayton, North Carolina | 7 |
About this profile
What does Thia Jim inspect?
Thia Jim appears on 1 document on file covering 1 site, mostly in North Carolina.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.110 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Thia Jim is dated Dec 13, 2018.